Eucalyptol (Cineole)
Eucalyptol (1,8-cineole) is the cooling, camphor-like heart of eucalyptus oil, also abundant in rosemary. It has the strongest human evidence of any terpene: oral capsules reduced COPD exacerbations and improved asthma and sinusitis in placebo-controlled trials. Swallowed neat, the oil is dangerous.
Aroma
Mint, Fresh, Cooling
Sensory Descriptors
Boiling Point
176°C (349°F)
Found In
Eucalyptus, Tea Tree, Rosemary, Bay Leaves, Sage
Effects
Respiratory Health, Anti-inflammatory, Anti-oxidant, Analgesic, Anti-microbial
Industries
Aroma and sensory profile
Eucalyptol is the smell of a chest rub. Fragrance references type it herbal and describe it at 10 percent dilution as eucalyptus, herbal, camphor, and medicinal; its flavor is minty, camphoraceous, cooling, eucalyptus, and medicinal [1]. The cooling is the defining quality. It reads as cold without being sweet the way menthol is, which is why eucalyptol says "clinic" where menthol says "candy," and why the two are paired in lozenges and mouthwashes. In rosemary it is the fresh, penetrating top note above the herb's warmer body.
The molecule is a monoterpene ether, 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, with a bridged ring that makes it symmetric; it has no stereocenter, so there are no enantiomers and no mirror-image forms to compare [2]. The oxygen bridge also makes it stable: it does not autoxidize the way the hydrocarbon terpenes do, which matters for the skin discussion below.
Effects and research
Eucalyptol is the one terpene on this site with a body of controlled human trials, all using oral capsules of the pure compound.
In chronic obstructive pulmonary disease, 242 patients with stable disease took 200 milligrams of cineole or placebo three times daily for six months over winter; frequency, severity, and duration of exacerbations were significantly lower in the cineole group [3]. In asthma, 247 patients took the same dose for six months alongside their usual therapy and showed significantly more improvement across the trial's combined criteria, with lung function, symptoms, and quality-of-life scores each reaching significance [4]. In acute nonpurulent rhinosinusitis, 152 patients took two 100 milligram capsules three times daily for seven days; symptom scores at day seven were 3.0 in the cineole group against 9.2 for placebo [5]. A 2020 review by the trialists frames the mechanism as mucolytic and anti-inflammatory and reports the COPD exacerbation reduction as 38.5 percent [6].
Two cautions. These trials come from one German research group and one manufacturer's product, and independent replication is thin. And they tested swallowed capsules at 600 milligrams a day, not inhaled vapor or diluted oil, so they do not validate steam inhalation or aromatherapy use; those routes have no comparable evidence in the sources reviewed.
Natural sources
The name comes from Eucalyptus globulus, in whose oil the compound was first characterized alongside Melaleuca leucadendron, and it has since been reported in roughly 270 other essential oils [2]. Eucalyptus oils are the commercial source: a 2023 analysis of Eucalyptus globulus oil found 63.1 percent 1,8-cineole with p-cymene, alpha-pinene, and limonene as minor components [7], and Eucalyptus polybractea oil has been reported at up to 91 percent [2]. Rosemary is the kitchen source; across six rosemary oils from different origins, 1,8-cineole ran from 16.3 to 29.4 percent, second only to alpha-pinene [8]. Vegetation releases enough of it that HSDB counts it as a major monoterpene emitted into the atmosphere [2]. In cannabis it is a trace component.
Boiling point and vaporization
PubChem compiles the boiling point of 1,8-cineole as 176 °C and 176 to 177 °C from the Hazardous Substances Data Bank, 176 to 177 °C from JECFA, 176.4 °C from DrugBank, and 349 to 351 °F from CAMEO Chemicals [2]. This profile uses 176 °C (349 °F), the same as limonene. It is volatile enough to carry on steam, which is the basis of the traditional inhalation, and it survives brief cooking better than pinene or myrcene. No thermal degradation study of eucalyptol was found in the sources reviewed; the dabbing study that produced benzene and methacrolein tested only hydrocarbon terpenes, and the ether structure would be expected to behave differently.
Safety and regulation
Eucalyptol is listed by the US Food and Drug Administration as a permitted synthetic flavoring substance at 21 CFR 172.515, under the entry "Eucalyptol; 1,8-epoxy-p-menthane; cineole" [9]. At 600 milligrams a day for six months, the controlled trials above reported no safety signal [3][4].
The hazard is the undiluted oil. In two adult cases, ingestion of around 15 milliliters of eucalyptus oil produced seizures and consciousness depressed enough to require intubation [10]. In children the margin is smaller: three pediatric patients developed seizures within 15 to 25 minutes of ingesting eucalyptus oil, with a syndrome of depressed consciousness, ataxia, seizures, and vomiting [11]. Cineole is the toxic constituent, and medicinal oils are standardized to at least 90 percent of it [11]. Eucalyptus oil belongs out of reach of children. No skin sensitization data comparable to limonene and linalool were found, consistent with its resistance to autoxidation.
Industries and uses
Pharmaceuticals: purified cineole is sold in some countries as an oral respiratory medicine, and it is the compound behind the trials above [3][4][5]. Culinary: it holds FDA flavoring status and gives the cooling, camphoraceous note in mint and eucalyptus confectionery [1][9]. Aromatherapy: eucalyptus and rosemary oils, its richest carriers, are staples of the practice, but the human evidence is for capsules, not inhalation [7][8]. Fragrance: it is a fresh, medicinal top note in herbal and fougere compositions and in oral-care flavors [1].
References
- 1,8-cineole, CAS 470-82-6. The Good Scents Company
- 1,8-Cineole, CID 2758: computed properties, boiling point, natural occurring sources (HSDB, Fenaroli). PubChem, National Library of Medicine
- Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respiratory Research (2009)
- Patients with asthma benefit from concomitant therapy with cineole: a placebo-controlled, double-blind trial. Journal of Asthma (2012)
- Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope (2004)
- New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach. Advances in Therapy (2020)
- Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil. Plants (Basel) (2023)
- Chemotypic Characterization and Biological Activity of Rosmarinus officinalis. Foods (2017)
- 21 CFR 172.515, Synthetic flavoring substances and adjuvants. Code of Federal Regulations (Legal Information Institute)
- Eucalyptus oil poisoning: two case reports. Journal of Medical Case Reports (2019)
- Eucalyptus Oil-Induced Seizures in Children: Case Reports and Review of the Literature. Journal of Neurosciences in Rural Practice (2021)